Warner-Lambert et al. v. Purepac Pharmaceutical et al. (D.N.J.). Michael Patunas was part of a trial team for LDG client Teva Pharmaceuticals in a patent infringement action concerning Teva's AB-rated generic equivalent to Pfizer's Neurontin®. A favorable settlement was reached two weeks into a scheduled seven-week jury trial.
